Company reported $8.2 million in cash and cash equivalents at December 31, 2025 and raised additional $6.5 million in gross ...

Nuvation Bio is downgraded from Buy to Hold as its stock price now reflects improved Ibtrozi rollout visibility and strong fundamentals. Ibtrozi's commercial launch is robust, with early patient ...

Bio-Rad is a "picks and shovels" company in the life sciences industry, but lacks standout growth, margins, or returns, and that has been largely true for more than two decades. Recent trends in the ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Be Biopharma, Inc. (“Be Bio” or “the Company”), a leader in the discovery and development of engineered B Cell Medicines (BCMs), today announced key milestones ...

On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical company, with $30 million paid upfront and up to $1.3 billion in developmental ...

For the first time, scientists can now leverage the reproducibility of ioCells to study how the four major CNS cell types interact and contribute to neurological diseases. This enables more precise ...

If you were tasked with resurrecting an extinct animal, where would you even begin? Colossal Biosciences, a synthetic biology company founded in 2021 by a Harvard geneticist George Church and ...

NEW YORK and SANTA BARBARA, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Phytanix Bio, an innovative pharmaceutical company dedicated to the development of therapeutics based on cannabinoid and ...

The financing, led by Supply Change Capital with participation by Mondelez International’s SnackFutures Ventures and other backers, will help the 2-year-old company scale production of its ...

FibroBiologics, Inc., a clinical-stage biotechnology company specializing in fibroblast-based therapies, announced that CEO Pete O’Heeron will present a company update at the BIO International ...

TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation ...